Myeloid cells are known to suppress antitumour immunity 1 . However, the molecular
drivers of immunosuppressive myeloid cell states are not well defined. Here we used single-cell …

… We describe a case of primary pulmonary NUT-C in a previously healthy young male and …
However, a combination of IHC and FISH analysis allows for NUT-C diagnosis with sensitivity …

BACKGROUND Epothilones and taxanes interfere with microtubule function. Ixabepilone,
which is an epothilone‐B analog, has activity against taxane‐resistant cell lines and as first‐…

Patients with lung cancer are especially vulnerable to coronavirus disease 2019 (COVID-19)
with a greater than sevenfold higher rate of becoming infected with severe acute respiratory …

During the global pandemic with COVID-19, early reports indicated that cancer patients in
general, and lung cancer patients in particular, who were infected with SARS-CoV-2 had high …

TPS9139 Background: Although tumor microenvironments may contain chronic inflammatory
cells, this milieu can lead to immune evasion and may contribute to resistance to …

During the COVID-19 pandemic, monitoring hospitalizations and reported infections had a
public health focus. However, the impact of ‘‘silent spread’’by asymptomatic or unaware …

Background Cancer patients’ treatment is often dispersed across multiple physician communities
that may not exchange information. We measured the association between this type of …

Background Metformin has been shown to have anti-neoplastic activity in non-small cell
lung cancer (NSCLC) in both preclinical and observational studies, however this has never …

2649 Background: Immune checkpoint blockade (ICB) is a standard therapeutic option for
certain patients with solid tumors, often leading to durable responses. Immune-related …